Webinar: Diversity, Equity and Inclusion in Rare Disease Clinical Trials
1:14:41
Description
Related Videos
View More
View Less
1:14:41
32:11
57:01
59:59
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
58:34
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03